Kevin Brady - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Kevin Brady

Showing results (41-50 of 45) with videos related to

Pageof 5

Sort By:

You have reached the last page of results.This site can display upto 45 results.

Molecular Therapy : the Journal of the American Society of Gene Therapy|June 28, 2012

Safe, long-term hepatic expression of anti-HCV shRNA in a nonhuman primate modelDavid A Suhy, Shih-Chu Kao, Tin Mao, et al.

ACS Chemical Biology|August 18, 2021

The Chemical Synthesis of Knob Domain Antibody FragmentsAlex Macpherson, James R Birtley, Robert J Broadbridge, et al.

Molecular Therapy : the Journal of the American Society of Gene Therapy|October 6, 2011

Uptake, efficacy, and systemic distribution of naked, inhaled short interfering RNA (siRNA) and locked nucleic acid (LNA) antisenseSterghios A Moschos, Manfred Frick, Bruce Taylor, et al.

Clinical and Translational Medicine|March 21, 2025

Preclinical B cell depletion and safety profile of a brain-shuttled crystallizable fragment-silenced CD20 antibodyVanessa L Schumacher, Solen Pichereau, Juliana Bessa, et al.

Science Translational Medicine|October 5, 2021

An affinity-enhanced, broadly neutralizing heavy chain-only antibody protects against SARS-CoV-2 infection in animal modelsBert Schepens, Loes van Schie, Wim Nerinckx, et al.

Pageof 5

Search research articles

Showing results (41-50 of 45) with videos related to

Sort By:

Pageof 5

You have reached the last page of results.This site can display upto 45 results.

Molecular Therapy : the Journal of the American Society of Gene Therapy|June 28, 2012

Safe, long-term hepatic expression of anti-HCV shRNA in a nonhuman primate modelDavid A Suhy, Shih-Chu Kao, Tin Mao, et al.

ACS Chemical Biology|August 18, 2021

The Chemical Synthesis of Knob Domain Antibody FragmentsAlex Macpherson, James R Birtley, Robert J Broadbridge, et al.

Molecular Therapy : the Journal of the American Society of Gene Therapy|October 6, 2011

Uptake, efficacy, and systemic distribution of naked, inhaled short interfering RNA (siRNA) and locked nucleic acid (LNA) antisenseSterghios A Moschos, Manfred Frick, Bruce Taylor, et al.

Clinical and Translational Medicine|March 21, 2025

Preclinical B cell depletion and safety profile of a brain-shuttled crystallizable fragment-silenced CD20 antibodyVanessa L Schumacher, Solen Pichereau, Juliana Bessa, et al.

Science Translational Medicine|October 5, 2021

An affinity-enhanced, broadly neutralizing heavy chain-only antibody protects against SARS-CoV-2 infection in animal modelsBert Schepens, Loes van Schie, Wim Nerinckx, et al.

Pageof 5